Option Care Health, Inc. $OPCH Position Boosted by Prudential Financial Inc.
by Jessica Moore · The Cerbat GemPrudential Financial Inc. grew its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 32.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 396,158 shares of the company’s stock after purchasing an additional 97,465 shares during the period. Prudential Financial Inc.’s holdings in Option Care Health were worth $12,867,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of OPCH. USA Financial Formulas acquired a new stake in Option Care Health during the second quarter worth about $26,000. Northwestern Mutual Wealth Management Co. boosted its stake in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock valued at $31,000 after acquiring an additional 836 shares during the period. Brooklyn Investment Group grew its holdings in shares of Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock valued at $42,000 after purchasing an additional 780 shares during the last quarter. Wealthquest Corp acquired a new stake in shares of Option Care Health during the 1st quarter worth approximately $66,000. Finally, Allworth Financial LP lifted its holdings in shares of Option Care Health by 126.6% in the 2nd quarter. Allworth Financial LP now owns 2,237 shares of the company’s stock worth $73,000 after purchasing an additional 1,250 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the company. Citigroup restated an “outperform” rating on shares of Option Care Health in a research note on Friday, October 31st. Weiss Ratings reissued a “hold (c-)” rating on shares of Option Care Health in a report on Tuesday. JMP Securities set a $36.00 price objective on shares of Option Care Health in a report on Friday, October 31st. TD Cowen cut their price objective on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research report on Monday, November 3rd. Finally, Wall Street Zen lowered shares of Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Nine research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average price target of $35.67.
View Our Latest Report on Option Care Health
Insiders Place Their Bets
In other news, Director Norman L. Wright purchased 3,411 shares of the business’s stock in a transaction dated Tuesday, September 9th. The shares were acquired at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the acquisition, the director directly owned 15,501 shares of the company’s stock, valued at $454,334.31. The trade was a 28.21% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the purchase, the director owned 413,390 shares in the company, valued at approximately $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.64% of the stock is currently owned by corporate insiders.
Option Care Health Price Performance
Shares of NASDAQ OPCH opened at $31.02 on Friday. Option Care Health, Inc. has a twelve month low of $22.29 and a twelve month high of $35.53. The company has a market capitalization of $4.92 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 1.74 and a beta of 0.88. The firm has a 50-day moving average of $27.93 and a two-hundred day moving average of $29.43. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
- Five stocks we like better than Option Care Health
- Stock Market Upgrades: What Are They?
- Keysight Technologies’ Surge: The Market Wakes Up to This AI Play
- How to start investing in penny stocks
- Is American Express the Credit Stock For a K-Shaped Economy?
- Options Trading – Understanding Strike Price
- Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).